Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
05/2001
05/09/2001EP1097921A1 Phenylhydrazines
04/2001
04/26/2001WO2001029034A1 Quinuclidine acrylamides
04/26/2001WO2001029000A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
04/26/2001CA2386049A1 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
04/24/2001US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain
04/12/2001WO2001025215A2 Method for selectively dissociating cyclic carboxylic acid anhydrides
04/12/2001DE19947953A1 Verfahren zur selektiven Spaltung cyclischer Carbonsäureanhydride Process for the selective cleavage of cyclic anhydrides
04/11/2001EP0936866A4 Compounds, compositions and methods for treating antibiotic-resistant infections
04/11/2001CN1290685A Continously hydrogen adding method
04/05/2001WO2001023385A2 Novel tropane analogs
04/05/2001WO2001023383A1 Quinuclidine compounds and drugs containing the same as the active ingredient
04/05/2001CA2384692A1 Novel tropane analogs
04/04/2001EP1088819A2 6-azauracil derivatives as thyroid receptor ligands
04/04/2001CN1290264A Triazine angiogenesis inhibitors
04/04/2001CN1064042C Intermediate of benzazepine derivative
03/2001
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001EP0674635B1 Quinuclidine derivatives as squalene synthase inhibitors
03/28/2001CN1063749C Azabicyclic esters of carbamino acids used in therapy
03/27/2001US6207678 Used for treating inflammatory disease such as arthritis, psoriasis, asthma or inflammatory bowel disease, central nervous system disorder such as anxiety, depression, dementia or psychosis, gastrointestinal disorders
03/21/2001EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/14/2001EP1082959A1 NK1 Antagonists for the treatment of depression
03/08/2001WO2001016107A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
03/08/2001WO2001015532A1 Azabicyclo and azacyclo oxime and amine compounds as pesticides
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001CA2383307A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
03/07/2001EP0840732B1 Substituted benzolactam compounds as substance p antagonists
03/01/2001WO2001014310A1 PLEUROMUTILIN β-KETOESTERS
02/2001
02/28/2001EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/27/2001US6194416 Central nervous system disorders; alzheimer's disease
02/22/2001WO2001011968A2 Heterocyclic spiro compounds as pesticides
02/21/2001CN1284505A Azabicyclic compound
02/20/2001US6191139 Antidepressant
02/20/2001US6190852 Coupler provides a desirably narrow spectrographic absorption curve.
02/14/2001EP0865441B1 1,2,3-thiadiazole carboxylic acid (thio)esters and the use thereof as a pest control agent or as a microbicide
02/13/2001US6187776 Heterocyclic compounds and their use
02/07/2001EP1074552A2 Process for the preparation of a highly pure phenothiazine compound
02/07/2001EP1074256A2 Depolarizing skeletal muscle relaxants
02/07/2001CN1283197A Pleuromutilin derivatives as antimicrobials
01/2001
01/31/2001EP1071423A1 Antagonists of gonadotropin releasing hormone
01/31/2001CN1282326A Anilide derivative, production and use thereof
01/30/2001US6180647 Gastrointestinal disorders; nervous system disorders
01/30/2001US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation
01/30/2001US6180551 Enantioselective dihydroxylation
01/24/2001EP1070711A2 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
01/23/2001CA2197451C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
01/21/2001CA2314373A1 Heteroaryl-substituted pyrrole derivatives, their preparation and their thereapeutic uses
01/18/2001WO2001004118A2 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands
01/18/2001WO1999064049A9 Novel antibacterial agents
01/17/2001EP1068195A1 Antagonists of gonadotropin releasing hormone
01/17/2001EP1067930A1 Antagonists of gonadotropin releasing hormone
01/17/2001CN1280578A Bis-quaternary ammonium derivatives as neuromuscular relaxants
01/17/2001CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase
01/16/2001US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma
01/16/2001US6174896 Quinuclidine derivatives and medicinal composition thereof
01/11/2001WO2001002414A1 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
01/11/2001WO2001002405A1 Quinuclidine derivatives for treatment of neurological disorders
01/11/2001WO2001002396A1 Novel benzo[f]naphthyridine, preparation and compositions containing them
01/09/2001US6172239 Psychological, nervous system disorders
01/09/2001US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto
01/04/2001WO2001000587A1 Azolylbenzamides and analogues and their use for treating osteoporosis
01/04/2001WO2001000208A1 Substituted pyridones having cytokine inhibitory activity
01/03/2001EP1064285A1 Novel cephalotaxane derivatives and process for their preparation
01/03/2001CN1060168C Xanthene derivant, its preparation method and medicinal composition containing same
01/02/2001CA2068064C Fibrinogen receptor antagonists
12/2000
12/28/2000WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists
12/28/2000CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions
12/27/2000EP1063224A1 Continuous hydrogenation process
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/26/2000US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents
12/23/2000CA2311996A1 Continuous hydrogenation process
12/12/2000US6159989 Antagonists of gonadotropin releasing hormone
12/07/2000WO2000073304A1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
12/07/2000WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
11/2000
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000043354A3 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000CA2372494A1 Compounds having cytokine inhibitory activity
11/22/2000EP1053236A1 Pyrdiyl-briidgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
11/22/2000CN1058728C Hydoxymethyl quenuaclidine catalyst compsns. for making polyurethane foams
11/21/2000US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/15/2000EP1051374A1 The use of compressed carbon dioxide in chemical reactions
11/14/2000US6147088 Antagonists of gonadotropin releasing hormone
11/02/2000WO2000064877A1 2-aminoquinolinecarboxamides: neurokinin receptor ligands
10/2000
10/31/2000US6140530 Quinidine conjugates and their use in immunoassays
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000CA2368829A1 Adamantane derivatives
10/18/2000CN1270170A Resolution of [R,S]-alpha-(methoxyimido)-alpha-(1-azebicyclic [2,2,2] octa-3-radical) acetonitrile
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/11/2000CN1269775A Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 58